The Ditible
KATHMANDU, NEPAL – A recent study has revealed a concerning trend within the Kathmandu metropolis, with 110 cases of leprosy recorded during the fiscal year 2079-80 BS (2022-23). The study was conducted by the Leprosy Control and Disabilities Management Section under the Epidemiology and Disease Control Division of the Department of Health Services, with support from government and non-government organizations.
In response to this finding, the NGO NLR Nepal has launched an awareness program on leprosy, working with local representatives, health workers, and volunteers. The program aims to educate the community about this infectious disease, the risks of physical impairment if untreated, and the availability of effective treatment options.
Bikashman Singh, Executive Director of NLR Nepal, stressed the crucial need for early detection and treatment, emphasizing, “Leprosy is preventable through medication.” He noted that leprosy, caused by the bacteria Mycobacterium leprae, is transmitted primarily through respiratory routes, but is generally considered less communicable.
Dr. Prashanna Napit, Section Chief, added that nationwide statistics are also worrying. A total of 2,522 new leprosy patients were identified in Nepal during the fiscal year 2022-23. Madhesh Province reported the most significant number of cases, with 944 individuals diagnosed.
About Leprosy:
- Leprosy, also known as Hansen’s Disease, is a chronic infectious disease caused by bacteria.
- It primarily affects the skin, peripheral nerves, eyes, and the lining of the nose.
- If left untreated, leprosy can lead to severe disabilities and disfigurement.
- Early diagnosis and treatment with multidrug therapy (MDT) are crucial for preventing complications and stopping the spread of the disease.
